Your browser is no longer supported. Please, upgrade your browser.
Settings
ENDP Endo International plc daily Stock Chart
ENDP [NASD]
Endo International plc
Index- P/E- EPS (ttm)-14.81 Insider Own0.40% Shs Outstand223.01M Perf Week2.81%
Market Cap2.53B Forward P/E3.34 EPS next Y3.40 Insider Trans-0.34% Shs Float221.86M Perf Month-13.49%
Income-3300.50M PEG- EPS next Q0.72 Inst Own97.90% Short Float10.41% Perf Quarter5.68%
Sales4.08B P/S0.62 EPS this Y-850.90% Inst Trans-0.65% Short Ratio3.33 Perf Half Y-30.24%
Book/sh9.81 P/B1.16 EPS next Y-5.00% ROA-21.50% Target Price14.94 Perf Year-17.09%
Cash/sh- P/C- EPS next 5Y-12.24% ROE-78.80% 52W Range9.70 - 24.93 Perf YTD-31.09%
Dividend- P/FCF4.40 EPS past 5Y-61.60% ROI-25.30% 52W High-53.39% Beta0.60
Dividend %- Quick Ratio0.90 Sales past 5Y9.70% Gross Margin36.00% 52W Low19.79% ATR0.62
Employees4894 Current Ratio1.10 Sales Q/Q7.70% Oper. Margin-84.40% RSI (14)48.70 Volatility4.79% 4.86%
OptionableYes Debt/Eq3.77 EPS Q/Q-85.80% Profit Margin-82.90% Rel Volume0.61 Prev Close11.35
ShortableYes LT Debt/Eq3.76 EarningsAug 08 BMO Payout- Avg Volume6.94M Price11.62
Recom2.70 SMA20-2.09% SMA50-2.34% SMA200-19.85% Volume3,500,128 Change2.38%
Jun-16-17Initiated Cantor Fitzgerald Neutral $12
Jun-09-17Downgrade Stifel Buy → Hold $22 → $15
May-25-17Reiterated Mizuho Buy $18 → $19
Feb-22-17Initiated Canaccord Genuity Hold $14
Jan-31-17Reiterated Mizuho Buy $25 → $15
Jan-20-17Downgrade JP Morgan Overweight → Neutral
Jan-05-17Downgrade Citigroup Buy → Neutral
Dec-07-16Resumed Oppenheimer Perform
Nov-11-16Reiterated Mizuho Buy $29 → $25
Nov-10-16Upgrade Susquehanna Neutral → Positive
Nov-09-16Reiterated RBC Capital Mkts Outperform $26 → $21
Sep-29-16Upgrade Northland Capital Market Perform → Outperform
Aug-12-16Upgrade Mizuho Neutral → Buy $16 → $29
Jun-13-16Upgrade Mizuho Underperform → Neutral $13 → $16
Jun-06-16Initiated Goldman Neutral $20
May-18-16Reiterated Stifel Buy $75 → $25
May-09-16Reiterated Deutsche Bank Buy $61 → $31
May-06-16Reiterated Stifel Buy $90 → $75
May-06-16Reiterated Barclays Equal Weight $37 → $28
May-06-16Downgrade Piper Jaffray Overweight → Neutral
Jun-26-17 03:53PM  ETFs with exposure to Endo International Plc : June 26, 2017 Capital Cube
02:17PM  Valeant Pharma: A Debt Swap? Barrons.com
12:55PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Endo International plc (ENDP) Accesswire
10:22AM  Edited Transcript of ENDP earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents
Jun-23-17 08:01PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc - ENDP PR Newswire
Jun-22-17 12:36AM  [$$] Missouri Files Its Own Suit Against Opioid-Painkiller Producers The Wall Street Journal
Jun-21-17 03:35PM  Missouri attorney general sues opioid manufacturers American City Business Journals
12:38PM  Missouri sues opioid manufacturers, joining two other U.S. states Reuters
Jun-20-17 08:04AM  Should Investors Steer Clear of Opioid Drug Stocks? Motley Fool
Jun-16-17 03:43PM  ETFs with exposure to Endo International Plc : June 16, 2017 Capital Cube
09:50AM  Is Endo International (ENDP) a Great Stock for Value Investors? Zacks
09:10AM  Cantors First Take: Bullish on Valeant Pharmaceuticals Intl Inc (VRX), Sidelined on Endo International (ENDP) SmarterAnalyst
Jun-15-17 08:35AM  Mallinckrodt sued by Tennessee prosecutors American City Business Journals
Jun-14-17 09:44AM  These 2 Marijuana Stocks Plunged Last Week: Should You Be Buying? Motley Fool
09:20AM  Endo International Plc :ENDP-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 Capital Cube
Jun-13-17 03:35PM  William Blair Shares Two Cents on Endo International plc (ENDP) SmarterAnalyst
03:28PM  Endo Works With FDA on Request to Pull Opioid Pain Pill Bloomberg
03:46AM  Why Is Endo (ENDP) Down 4.7% Since the Last Earnings Report? Zacks
Jun-12-17 05:52PM  SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of Endo International plc Business Wire
05:05PM  Endo Luxembourg Finance I Company S.a.r.l. -- Moody's: Withdrawing Opana ER in the US following an FDA request would be credit negative for Endo Moody's
04:44PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Endo International plc (ENDP) PR Newswire
01:14PM  IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Endo International plc and Advises Investors with Losses to Contact the Firm Business Wire
12:29PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Endo International plc -- ENDP Business Wire
12:00PM  Alkermes Looks To Capitalize On Opioid Epidemic Through Aggressive Lobbying Benzinga
10:15AM  Company News for June 12, 2017 Zacks
09:31AM  Endo International Plc breached its 50 day moving average in a Bearish Manner : ENDP-US : June 12, 2017 Capital Cube
08:03AM  Is Cannabis The Solution to America's Terrifying Opioid Crisis? Motley Fool
Jun-11-17 02:27PM  Opioid Stocks Feel the Pressure of FDA Measures Investopedia
Jun-10-17 03:22PM  Is the FDA a Big Risk to This Company's Marijuana Plans? Motley Fool
Jun-09-17 05:30PM  New FDA boss sends message on addictive opioids. Will this East Bay drug maker benefit? American City Business Journals -16.62%
05:20PM  Depomed, Insys Shares Down After FDA Decision on Endo's Opana ER TheStreet.com
04:39PM  Biotech Stocks To Watch And Pharma Industry News Investor's Business Daily
04:07PM  How Endo's Opioid Pitfall Could Be A Boon For These Drugmakers Investor's Business Daily
03:29PM  IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of Endo International plc and Encourages Investors with Losses to Contact the Firm Business Wire
02:54PM  Arons & Arons, LLC. Announces Investigation on Behalf of Endo International plc Investors Business Wire
02:21PM  INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Endo International plc Business Wire
02:15PM  Why Endo's Bad News Sent Collegium Pharmaceutical Shares Soaring 10% Motley Fool
02:14PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of the Commencement of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Endo International plc Business Wire
01:12PM  Endo's Pain Is Good For Collegium, Mixed For Impax Barrons.com
12:26PM  Endo Stock's Fall Could Be a Sign of Things to Come The Wall Street Journal
12:12PM  Glancy Prongay & Murray LLP Commences Investigation on Behalf of Endo International plc Investors Business Wire
11:34AM  Endo International: Flagging the Downside Risk Barrons.com
11:04AM  Story Stocks from Briefing.com Briefing.com
10:53AM  Collegium's stock jumps on belief its opioid drug will get a boost from a rival's woes MarketWatch
10:42AM  The FDA is getting a lot more aggressive about fighting the opioid crisis Business Insider
10:30AM  Who Wins From Endos Opana Getting Pulled From the Market 24/7 Wall St.
09:55AM  US STOCKS-Wall St higher as investors shrug off UK election impact Reuters
09:30AM  Stocks to Watch: Pandora, VeriFone Systems, Nvidia, Cloudera The Wall Street Journal
09:08AM  Canaccord Lifts Price Target on Valeant Pharmaceuticals Intl Inc (VRX), Cuts Endo International plc SmarterAnalyst
09:06AM  Wall Street tipped for a modest gain as investors turn attention to Fed MarketWatch
09:06AM  Endo Asked to Withdraw Pain Drug-Opana ER by FDA, Stock Down Zacks
08:43AM  3 Stocks to Watch on Friday: Cloudera Inc (CLDR), Endo International plc (ENDP) and DuPont Fabros Technology, Inc. (DFT) InvestorPlace
08:00AM  Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals Accesswire
07:45AM  Morning Movers: Endo Tumbles, Teck Resources Tanks, Ascena Slips Barrons.com
01:20AM  [$$] FDA Pushes to Get Endos Opana ER Painkiller Off the Market The Wall Street Journal
Jun-08-17 07:01PM  FDA asks drugmaker to stop selling its opioid painkiller Associated Press +11.13%
06:43PM  U.S. asks drug maker Endo to withdraw opioid amid abuse crisis Reuters
05:47PM  Endo Response to June 8, 2017 FDA Meeting Related to OPANA® ER CNW Group
05:36PM  After-hours buzz: ENDP, ASNA & more CNBC
05:29PM  [$$] FDA Pushes to Get Endo's Opana ER Opioid Off the Market The Wall Street Journal
05:19PM  Endo Crashes After FDA Asks It To Pull Opioid Drug From Shelves Investor's Business Daily
05:11PM  Endo Shares Down as FDA Seeks Removal of Opioid Pain Medication TheStreet.com
05:00PM  FDA asks Endo to stop selling opioid, in first such move MarketWatch
04:35PM  FDA asks Endo to withdraw Opana ER opioid, shares fall Reuters
04:31PM  FDA Seeks to Pull Pain Pill Off Market, Citing Risk of Abuse Bloomberg
04:29PM  FDA requests drug company to remove drug from market CNBC Videos
04:18PM  Here's Why Endo International plc Stock Surged Today Motley Fool
12:54PM  Valeant Pharmaceuticals: Bigger is Better Barrons.com
Jun-07-17 05:12PM  Endo Announces Entry of Significant Case Management Order in Mesh Multidistrict Litigation CNW Group
Jun-06-17 02:59PM  Veloxis Pharmaceuticals A/S and Endo Ventures Limited Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Envarsus XR® in Canada PR Newswire
08:31AM  Why Endo International plc Rose 12.9% in May Motley Fool
Jun-01-17 01:06AM  PRESS DIGEST - Wall Street Journal - June 1 Reuters
12:06AM  [$$] Ohio Sues Five Drugmakers, Saying They Fueled Opioid Crisis The Wall Street Journal
May-31-17 02:48PM  [$$] Ohio Sues Five Drug Firms, Saying They Fueled Opioid Crisis The Wall Street Journal
02:33PM  Ohio Going After Drug Makers for Fueling Opioid Crisis TheStreet.com
12:10PM  Johnson and Johnson, other drug companies accused of viol... CNBC Videos
May-26-17 07:30AM  Endo to Present at Goldman Sachs 38th Annual Global Healthcare Conference CNW Group
May-25-17 04:10PM  Teva Pharma, Eagle Pharma, Depomed Among Slew Getting Price Haircuts Investor's Business Daily
May-24-17 08:00AM  Today's Research Reports on Stocks to Watch: Endo International and Helios and Matheson Analytics Accesswire
May-19-17 01:33PM  Valeant Pharmaceuticals: IntriguedReally? Barrons.com
May-16-17 03:30PM  BDSI CEO on Belbuca revenue potential: We're on an upward trend American City Business Journals
May-15-17 08:59PM  New York county sues Purdue, J&J over opioid marketing Reuters
05:46PM  New York county sues Purdue, J&J over opioid marketing Reuters
01:00PM  These Stocks Show Change of Direction TheStreet.com
May-10-17 08:00AM  Today's Research Reports on Stocks to Watch: Endo International and Valeant Pharmaceuticals Accesswire
May-09-17 09:06PM  Edited Transcript of ENDP earnings conference call or presentation 9-May-17 12:30pm GMT Thomson Reuters StreetEvents +18.16%
02:07PM  Endo (ENDP) Beats on Q1 Earnings, Reaffirms '17 Guidance Zacks
01:02PM  Here's What's Behind Endo International plc's Rally Today Motley Fool
08:54AM  Endo (ENDP) Q1 Earnings Beat Estimates, Revenues in Line Zacks
07:45AM  Investor Network: Endo International Plc to Host Earnings Call Accesswire
07:25AM  Endo reports 1Q loss Associated Press
07:00AM  Endo profit beats on strong sales of generic drugs Reuters
06:40AM  Endo posts 7.7 percent rise in quarterly revenue Reuters
06:30AM  Endo Reports First-Quarter 2017 Financial Results PR Newswire
May-08-17 05:24PM  4 Drug Stocks Poised to Beat this Earnings Season Zacks
May-06-17 02:27AM  [$$] Suits Dog Guggenheim Chief Barrons.com
May-04-17 05:32PM  Is Endo (ENDP) Poised for a Beat This Earnings Season? Zacks
May-03-17 02:14PM  Generics Drop Across Board as DOJ Inquiry Expands TheStreet.com -6.52%
08:53AM  Perrigo Stock Sliding on DOJ Search TheStreet.com
May-02-17 05:14PM  Endo International Plc Value Analysis (NASDAQ:ENDP) : May 2, 2017 Capital Cube
Endo International plc develops, manufactures, and distributes pharmaceutical products and devices worldwide. Its U.S. Generic Pharmaceuticals segment provides tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics, and transdermal patches for pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's U.S. Branded Pharmaceuticals segment offers pain management products, such as Lidoderm, OPAN ER, Percocet, and Voltare Gel. This segment also provides Supprelin LA for central precocious puberty treatment; XIAFLEX for treating Peyronie's and Dupuytren's contracture diseases; Fortesta Gel for hypogonadism treatment; Testim Gel for the treatment of endogenous testosterone; Frova for migraine headaches; Valstar, a sterile solution for intravesical instillation of valrubicin; Vantas for the palliative treatment of advanced prostate cancer; Aveed for the treatment of low testosterone; TESTOPEL, a long-acting implantable pellet; and NASCOBAL, a nasal spray. Its International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, and oncology; generic, branded generic, and over-the-counter products in the areas of dermatology and anti-infectives; and healthcare services, products, and solutions to hospitals, pharmacies, and practitioners, as well as for government healthcare programs. The company also provides injectables for the treatment of pain, anti-infectives, cardiovascular, and other therapeutics areas. It sells its branded pharmaceuticals and generics directly, as well as through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Campanelli PaulPresident, CEOMar 16Buy10.722,30024,656207,120Mar 16 05:54 PM
Hutson Nancy JDirectorMar 09Sale10.825,32557,61731,252Mar 10 10:24 AM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,632188,000Nov 16 02:00 PM
KIMMEL ROGER HDirectorNov 15Sale17.387,000121,63268,362Nov 16 02:00 PM